Alyeska Investment Group
KITE

Alyeska Investment Group’s Kite Pharma, Inc. KITE Stock Holding History

Alyeska Investment Group’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-300,000
Closed -$53.9M – 592
2017
Q3 		$53.9M Buy
+300,000
New +$41.8M 0.4% 90
2014
Q3 		– Sell
-63,095
Closed -$1.82M – 504
2014
Q2 		$1.82M Buy
+63,095
New +$1.88M 0.04% 317

Alyeska Investment Group's KITE Position: Q4 2017 in Review

Alyeska Investment Group sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 300,000 shares — an estimated $53.9M sold.

Alyeska Investment Group first reported a position in KITE in Q2 2014 and held it in 2 quarters. The position peaked at $53.9M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Alyeska Investment Group reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Alyeska Investment Group sold 300,000 Kite Pharma, Inc. shares in Q4 2017, an estimated $53.9M.
  • Alyeska Investment Group first reported a position in Kite Pharma, Inc. in Q2 2014 and held it in 2 quarters.
  • Alyeska Investment Group's Kite Pharma, Inc. position peaked at $53.9M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Alyeska Investment Group's 13F filing for Q4 2017, filed 14 Feb 2018.